MedPath

Outer Thigh Study With Varied Treatment Parameters

Not Applicable
Completed
Conditions
Body Fat Disorder
Interventions
Device: The Zeltiq System
Registration Number
NCT02081209
Lead Sponsor
Zeltiq Aesthetics
Brief Summary

The purpose of this study is to compare the performance of the Zeltiq CoolSculpting System using various treatment parameters for non-invasive reduction of subcutaneous fat in the lateral thighs.

Detailed Description

The purpose of this study is to compare the performance of a cryolipolysis system using various treatment parameters for non-invasive reduction of subcutaneous fat in the lateral thighs.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
40
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Fat ReductionThe Zeltiq System-
Primary Outcome Measures
NameTimeMethod
Safety of the Zeltiq DeviceFrom enrollment through 16 week follow-up (approximately 5 months)

The number of unanticipated adverse device effects (UADEs) will be tabulated.

Percentage of Pre-treatment Images Correctly Identified.Baseline and 16 weeks post-treatment

Change in the treated vs. untreated areas will be assessed by observation of changes in surface contour and/or fat volume by an independent photo review of pre-treatment and post-treatment images of the treated areas. Reviewers will be practicing dermatologists or plastic surgeons. All reviewers will be blinded to post-treatment vs. baseline untreated area. The order in which images will be presented will be randomized; for each subject placement of the baseline, pre-treatment image will be randomized for each pair of subject images. Reviewers will be asked to select the baseline photos for each subject photo series and record selections on a data collection form. Criteria for evaluable photos for the purposes of the independent review: subject completed treatment regimen; subject has complete set of baseline photos; subject has a complete set of post-treatment photos; photos were taken using Zeltiq standard procedure. The expected success rate is 80%.

Secondary Outcome Measures
NameTimeMethod
Change in the Fat Layer of the Treated Area as Measured by Ultrasound16 weeks post-treatment

Change in the fat layer thickness will be calculated by comparison of pre-treatment and 16 week post-treatment ultrasound measurements taken in the area treated with the device, and in the adjacent untreated control area. The Sponsor's standardized techniques for obtaining ultrasound imaging will be used. Overall fat layer thickness changes were normalized for each subject by subtracting the change in control (untreated area) from the change in treated area to remove the influence of weight variations. Success is defined as, on average, at least a 1mm or greater reduction in fat layer thickness for the treated region as compared to the untreated control. Results indicate the mean fat layer reduction in mm.

Subject Satisfaction16-weeks post treatment

Subject satisfaction with the Zeltiq procedure as determined by the results of a subjects satisfaction questionnaire at the 16 week follow up visit. The questionnaire is composed of a 5-point Likert scale questions, as well as free text responses. Subjects will be asked to determine overall satisfaction with the treatment. The choices will be 1) very unsatisfied; 2) somewhat unsatisfied; 3) neither unsatisfied or satisfied; 4) somewhat satisfied; 5) very satisfied.

Trial Locations

Locations (2)

Marina Plastic Surgery

🇺🇸

Marina Del Rey, California, United States

Innovation Research Center

🇺🇸

Pleasanton, California, United States

© Copyright 2025. All Rights Reserved by MedPath